Wedbush Raises Price Target on Masimo Corp. (MASI) to $75 Following Investor Meeting

November 14, 2016 8:00 AM EST
Get Alerts MASI Hot Sheet
Price: $71.53 -0.36%

Rating Summary:
    8 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade MASI Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Wedbush reiterated an Outperform rating on Masimo Corp. (NASDAQ: MASI), and raised the price target to $75.00 (from $67.00), after hosting investor meetings. Wedbush believes that the Philips settlement may represent one of three most important events in the company’s history, with the other two being the inclusion of Masimo into GPO contracts in 2002 and the Nellcor patent settlement in 2006.

Analyst Tao Levy commented, "We hosted investor meetings with Masimo’s CFO in San Francisco and had the opportunity to discuss the recently signed Philips settlement, 3Q16 earnings results, and some of the company’s future growth opportunities. Overall, we came away incrementally more positive on the company’s ability to exceed expectations, and view MASI as one of MedTech’s better positioned SMID-cap growth companies. Furthermore, despite MASI’s share price hovering near all-time highs, we believe the shares can appreciate further."

For an analyst ratings summary and ratings history on Masimo Corp. click here. For more ratings news on Masimo Corp. click here.

Shares of Masimo Corp. closed at $61.17 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Earnings, Tao Levy

Add Your Comment